ObvioHealth

ObvioHealth is a company based in New York, United States, that provides the ObvioGo digital platform for clinical research. Its platform supports study design, recruitment and prescreening, eConsent and enrollment, logistics and device management, data capture and monitoring, ePRO + eCOA, virtual visits and support, and analysis and reporting, and it serves industries including CRO, medical devices, pharma and biotech, and consumer health.

ObvioHealth is a company in New York, United States. It provides the ObvioGo digital platform, which it describes as an enterprise-ready platform for tech-enabled trials. The platform covers study design, recruitment and prescreening, eConsent and enrollment, logistics and device management, data capture and monitoring, ePRO + eCOA, virtual visits and support, and analysis and reporting, and serves industries including CRO, medical devices, pharma and biotech, and consumer health.

Tech-enabled clinical trials delivering stronger evidence through the ObvioGo digital platform.

• ObvioGo

  An enterprise-ready digital platform for tech-enabled clinical trials, covering study design, recruitment and prescreening, eConsent and enrollment, logistics and device management, data capture and monitoring, ePRO + eCOA, virtual visits and support, and analysis and reporting.

• 2022-01-13

  ObvioHealth launches Augmented ePRO[6]ObvioHealth推出Augmented ePROprnewswire.com

  Reported: 2022-01-13

  ObvioHealth announced the launch of Augmented ePRO, a clinical-trial service combining AI-assisted ePRO instruments with a centralized clinical rating platform.

• 2021-09-30

  ObvioHealth and Anatara launch decentralized clinical trial in Australia[7]ObvioHealth与Anatara在澳大利亚启动去中心化临床试验prnewswire.com

  Reported: 2021-09-30

  ObvioHealth announced the launch of an Australian clinical trial with Anatara Lifesciences to evaluate the safety and efficacy of its GaRP complementary medicine for IBS-D.

• 2021-06-07

  ObvioHealth and Dedalus Group announce strategic partnership[8]ObvioHealth与Dedalus Group宣布战略合作prnewswire.com

  Reported: 2021-06-07

  ObvioHealth and Dedalus Group announced a strategic partnership to combine ObvioHealth's decentralized clinical trial tools with Dedalus's software solutions and connect clinical research with EHR data.

• 2020-05-20

  ObvioHealth raises $17 million[9]ObvioHealth 募得 1,700 万美元prnewswire.com

  Reported: 2020-05-20

  ObvioHealth announced that it had raised $17 million in its latest financing round.

1. 1Home | ObvioHealthobviohealth.com
2. 2About Us | ObvioHealthobviohealth.com
3. 3Careers | ObvioHealthobviohealth.com
4. 4Contact Us | ObvioHealthobviohealth.com
5. 5ObvioHealth (United States)wikidata.org
6. 6ObvioHealth推出Augmented ePROprnewswire.com
7. 7ObvioHealth与Anatara在澳大利亚启动去中心化临床试验prnewswire.com
8. 8ObvioHealth与Dedalus Group宣布战略合作prnewswire.com
9. 9ObvioHealth 募得 1,700 万美元prnewswire.com